HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Eleni Vasileiou Selected Research

BW 250 183

3/2021Invasive Fungal Diseases in Children with Hematological Malignancies Treated with Therapies That Target Cell Surface Antigens: Monoclonal Antibodies, Immune Checkpoint Inhibitors and CAR T-Cell Therapies.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Eleni Vasileiou Research Topics

Disease

4Infections
03/2021 - 09/2018
2Atrophy
01/2022 - 01/2021
2Optic Neuritis (Retrobulbar Neuritis)
01/2022 - 01/2020
2Neoplasms (Cancer)
01/2022 - 01/2021
2Ganglion Cysts (Ganglion)
01/2022 - 01/2021
2Mycoses (Diseases, Fungus)
09/2021 - 03/2021
2Multiple Sclerosis
01/2021 - 01/2020
2Candidemia
11/2020 - 09/2018
1Bites and Stings (Sting)
03/2021
1Leukemia
03/2021
1Lymphoma (Lymphomas)
03/2021
1Hematologic Neoplasms (Hematological Malignancy)
03/2021
1Thrombocytopenia (Thrombopenia)
01/2021
1Mucormycosis
01/2021
1Hemorrhage
01/2021
1Idiopathic Thrombocytopenic Purpura (Thrombocytopenic Purpura, Autoimmune)
01/2021
1Breakthrough Infections
12/2019
1Body Weight (Weight, Body)
12/2019
1Arthritis (Polyarthritis)
12/2019
1Biliary Atresia
01/2019
1Sepsis (Septicemia)
01/2019
1Bacteremia
01/2019
1Communicable Diseases (Infectious Diseases)
09/2018
1Atopic Dermatitis (Atopic Eczema)
02/2018

Drug/Important Bio-Agent (IBA)

3Retinaldehyde (Retinal)IBA
01/2022 - 01/2020
2Immune Checkpoint InhibitorsIBA
01/2022 - 03/2021
2Antifungal AgentsIBA
09/2021 - 01/2020
2Anti-Bacterial Agents (Antibiotics)IBA
11/2020 - 01/2019
1Myelin-Oligodendrocyte GlycoproteinIBA
01/2022
1Immunoglobulin G (IgG)IBA
01/2022
1Pharmaceutical PreparationsIBA
09/2021
1daratumumabIBA
03/2021
1combotoxIBA
03/2021
1pembrolizumabIBA
03/2021
1Rituximab (Mabthera)FDA Link
03/2021
1Abatacept (Orencia)FDA Link
03/2021
1Alemtuzumab (Campath)FDA Link
03/2021
1IpilimumabIBA
03/2021
1Chimeric Antigen ReceptorsIBA
03/2021
1BasiliximabFDA Link
03/2021
1NivolumabIBA
03/2021
1Alefacept (Amevive)FDA Link
03/2021
1Brentuximab VedotinIBA
03/2021
1atezolizumabIBA
03/2021
1Inotuzumab OzogamicinIBA
03/2021
1Monoclonal AntibodiesIBA
03/2021
1Immunotoxins (Immunotoxin)IBA
03/2021
1AntigensIBA
03/2021
1Surface Antigens (Surface Antigen)IBA
03/2021
1Gemtuzumab (Mylotarg)FDA Link
03/2021
1isatuximabIBA
03/2021
1ontuxizumabIBA
03/2021
1avelumabIBA
03/2021
1durvalumabIBA
03/2021
1tisagenlecleucelIBA
03/2021
1axicabtagene ciloleucelIBA
03/2021
1camrelizumabIBA
03/2021
1inolimomabIBA
03/2021
1BW 250 183IBA
03/2021
1ibritumomab tiuxetan (Zevalin)FDA Link
03/2021
1epratuzumabIBA
03/2021
1blinatumomabIBA
03/2021
1iratumumabIBA
03/2021
1tremelimumabIBA
03/2021
1ofatumumabFDA Link
03/2021
1immunotoxin HA22IBA
03/2021
1obinutuzumabIBA
03/2021
1Biosimilar PharmaceuticalsIBA
03/2021
1CeramidesIBA
01/2021
1eltrombopagFDA Link
01/2021
1Immunoglobulins (Immunoglobulin)IBA
01/2021
1Thrombopoietin ReceptorsIBA
01/2021
1AntibodiesIBA
01/2021
1Adrenal Cortex Hormones (Corticosteroids)IBA
01/2021
1SphingolipidsIBA
01/2021
1posaconazoleFDA Link
12/2019
1Hemoglobins (Hemoglobin)IBA
01/2019
1EchinocandinsIBA
09/2018
1liposomal amphotericin BFDA Link
09/2018
1Tobacco Smoke Pollution (Passive Smoking)IBA
02/2018

Therapy/Procedure

2Drug Therapy (Chemotherapy)
01/2021 - 09/2018
1Artificial Respiration (Mechanical Ventilation)
03/2021
1Catheters
03/2021
1Therapeutics
03/2021
1Precision Medicine
03/2021
1Splenectomy
01/2021
1Central Venous Catheters
11/2020
1Hepatic Portoenterostomy
01/2019